Studies on Prodrugs. VI. Preparation and Characterization of (5-Substituted 2-Oxo-1,3-dioxol-4-yl)methyl Esters of Mecillinam(Medicinal Chemistry,Chemical)
-
- 坂本 文夫
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
-
- 池田 昇司
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
-
- 平山 良一
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
-
- 森山 勝
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
-
- 外村 幹雄
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
-
- 塚本 悟郎
- Pharmaceuticals Research Center, Kanebo Co., Ltd.
この論文をさがす
抄録
As a new type of mecillinam prodrug, raecillinam (5-substituted 2-oxo-1,3-dioxol-4-yl)methyl esters were prepared. These esters were found to produce at least 4-fold higher mecillinam levels in blood than mecillinam itself after oral administration to mice. Mecillinam (5-methyl-2-oxo-1,3-dioxol-4-yl )methyl ester hydrochloride was hygroscopic, but its L-tartrate was not.
収録刊行物
-
- Chemical & pharmaceutical bulletin
-
Chemical & pharmaceutical bulletin 35 (2), 642-646, 1987-02-25
公益社団法人日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1570572702348403584
-
- NII論文ID
- 110006280947
-
- NII書誌ID
- AA00602100
-
- ISSN
- 00092363
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles